Literature DB >> 8058773

Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity.

D M Guidot1, M J Repine, J Y Westcott, J E Repine.   

Abstract

We found that intrinsic neutrophil 5-lipoxygenase activity was necessary for human neutrophil adherence and chemotaxis in vitro and human neutrophil-mediated acute edematous injury in isolated perfused rat lungs given interleukin 8 intratracheally. Treatment with either Zileuton (a specific reversible competitive inhibitor of 5-lipoxygenase) or MK886 (a specific irreversible inhibitor of the 5-lipoxygenase activator protein) prevented stimulated neutrophil adherence and chemotaxis (but not superoxide anion production) in vitro. Zileuton- or MK886-inhibited neutrophil chemotaxis was not restored by adding leukotriene B4 in vitro. Perfusion with neutrophils and either Zileuton or MK886, or with MK886-pretreated neutrophils (without adding MK886 to the perfusate), also prevented lung injury (reflected by lung weight gain and lung Ficoll retention) and perfusate leukotriene B4 increases in isolated rat lungs given interleukin 8 intratracheally. Again, adding leukotriene B4 to the perfusate did not damage interleukin 8-treated isolated lungs perfused with Zileuton-inhibited neutrophils. We conclude that intrinsic 5-lipoxygenase activity is required for neutrophil adherence and chemotaxis and neutrophil-mediated lung injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058773      PMCID: PMC44564          DOI: 10.1073/pnas.91.17.8156

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.

Authors:  B Samuelsson; S E Dahlén; J A Lindgren; C A Rouzer; C N Serhan
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

2.  MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes.

Authors:  C A Rouzer; A W Ford-Hutchinson; H E Morton; J W Gillard
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

3.  Preparation and assay of superoxide dismutases.

Authors:  J D Crapo; J M McCord; I Fridovich
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

4.  Inhibition of granulocyte adherence by ethanol, prednisone, and aspirin, measured with an assay system.

Authors:  R R MacGregor; P J Spagnuolo; A L Lentnek
Journal:  N Engl J Med       Date:  1974-09-26       Impact factor: 91.245

5.  Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay.

Authors:  P Pradelles; J Grassi; J Maclouf
Journal:  Anal Chem       Date:  1985-06       Impact factor: 6.986

6.  The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites.

Authors:  K A Haines; K N Giedd; A M Rich; H M Korchak; G Weissmann
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

7.  Production of arachidonic acid lipoxygenase products during platelet-neutrophil interactions.

Authors:  A J Marcus; M J Broekman; L B Safier; H L Ullman; N Islam; C N Serhan; G Weissmann
Journal:  Clin Physiol Biochem       Date:  1984

8.  Metabolism of leukotriene A4 by human erythrocytes. A novel cellular source of leukotriene B4.

Authors:  F Fitzpatrick; W Liggett; J McGee; S Bunting; D Morton; B Samuelsson
Journal:  J Biol Chem       Date:  1984-09-25       Impact factor: 5.157

9.  Effects of accidental trauma on cytokine and endotoxin production.

Authors:  R C Hoch; R Rodriguez; T Manning; M Bishop; P Mead; W C Shoemaker; E Abraham
Journal:  Crit Care Med       Date:  1993-06       Impact factor: 7.598

10.  The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate.

Authors:  J M Schröder
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  6 in total

1.  Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502.

Authors:  R A Hilger; M Köller; W König
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

2.  Decreased leukotriene release from neutrophils after severe trauma: role of immature cells.

Authors:  M Köller; M Wick; G Muhr
Journal:  Inflammation       Date:  2001-02       Impact factor: 4.092

3.  Functional genomic assessment of phosgene-induced acute lung injury in mice.

Authors:  George D Leikauf; Vincent J Concel; Kiflai Bein; Pengyuan Liu; Annerose Berndt; Timothy M Martin; Koustav Ganguly; An Soo Jang; Kelly A Brant; Richard A Dopico; Swapna Upadhyay; Clinton Cario; Y P Peter Di; Louis J Vuga; Emrah Kostem; Eleazar Eskin; Ming You; Naftali Kaminski; Daniel R Prows; Daren L Knoell; James P Fabisiak
Journal:  Am J Respir Cell Mol Biol       Date:  2013-09       Impact factor: 6.914

4.  Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infection.

Authors:  Stephen R Clark; Christopher J Guy; Martin J Scurr; Philip R Taylor; Ann P Kift-Morgan; Victoria J Hammond; Christopher P Thomas; Barbara Coles; Gareth W Roberts; Matthias Eberl; Simon A Jones; Nicholas Topley; Sailesh Kotecha; Valerie B O'Donnell
Journal:  Blood       Date:  2010-12-21       Impact factor: 22.113

5.  Leukotriene biosynthesis inhibition ameliorates acute lung injury following hemorrhagic shock in rats.

Authors:  Fadhil G Al-Amran; Najah R Hadi; Ali M Hashim
Journal:  J Cardiothorac Surg       Date:  2011-06-07       Impact factor: 1.637

6.  Circulating leukotriene B4 identifies respiratory complications after trauma.

Authors:  Birgit Auner; Emanuel V Geiger; Dirk Henrich; Mark Lehnert; Ingo Marzi; Borna Relja
Journal:  Mediators Inflamm       Date:  2012-03-07       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.